152 related articles for article (PubMed ID: 17907310)
1. Second tenofovir phase III study for the chronic HBV reaches primary endpoint.
AIDS Patient Care STDS; 2007 Aug; 21(8):607-8. PubMed ID: 17907310
[No Abstract] [Full Text] [Related]
2. Raltegravir as effective as efavirenz in 144-week data.
AIDS Patient Care STDS; 2009 Aug; 23(8):679-80. PubMed ID: 19694035
[No Abstract] [Full Text] [Related]
3. [Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV].
Bayonne Kombo ES; Gathse A
Med Mal Infect; 2013 Mar; 43(3):134-5. PubMed ID: 23434355
[No Abstract] [Full Text] [Related]
4. Elvucitabine data released at CROI.
AIDS Patient Care STDS; 2010 Mar; 24(3):198. PubMed ID: 20235383
[No Abstract] [Full Text] [Related]
5. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.
Marcellin P; Heathcote EJ; Buti M; Gane E; de Man RA; Krastev Z; Germanidis G; Lee SS; Flisiak R; Kaita K; Manns M; Kotzev I; Tchernev K; Buggisch P; Weilert F; Kurdas OO; Shiffman ML; Trinh H; Washington MK; Sorbel J; Anderson J; Snow-Lampart A; Mondou E; Quinn J; Rousseau F
N Engl J Med; 2008 Dec; 359(23):2442-55. PubMed ID: 19052126
[TBL] [Abstract][Full Text] [Related]
6. Two-year data released on Viread for chronic hepatitis B.
AIDS Patient Care STDS; 2008 Nov; 22(11):921. PubMed ID: 19025487
[No Abstract] [Full Text] [Related]
7. Replacement of tenofovir with adefovir may result in reactivation of hepatitis B virus replication.
Schildgen O; Hartmann H; Gerlich WH
Scand J Gastroenterol; 2006 Feb; 41(2):245-6. PubMed ID: 16484132
[No Abstract] [Full Text] [Related]
8. Impact of tenofovir versus abacavir on HIV-related endothelial dysfunction.
Francisci D; Falcinelli E; Belfiori B; Petito E; Fierro T; Baldelli F; Gresele P
AIDS Patient Care STDS; 2011 Oct; 25(10):567-9. PubMed ID: 21851265
[No Abstract] [Full Text] [Related]
9. [The first nucleotide analog permitted. New hepatitis B therapy helps the problem patients, too].
MMW Fortschr Med; 2003 Jun; 145(24):52. PubMed ID: 12866303
[No Abstract] [Full Text] [Related]
10. [Clinical data I. Clinical experience with tenofovir in combination with nonnucleoside analogue transcriptase inhibitors].
Bernardino de la Serna JI; Mora Rillo M; Arribas López JR
Enferm Infecc Microbiol Clin; 2008 Jun; 26 Suppl 8():7-12. PubMed ID: 19195432
[TBL] [Abstract][Full Text] [Related]
11. FDA notifications. FDA approves generic combination of efavirenz, lamivudine & tenofovir.
AIDS Alert; 2009 Nov; 24(11):130. PubMed ID: 19960612
[No Abstract] [Full Text] [Related]
12. [Antiviral treatment of chronic hepatitis B with adefovir dipivoxil].
Minami M; Okanoue T
Nihon Rinsho; 2004 Aug; 62 Suppl 8():336-9. PubMed ID: 15453341
[No Abstract] [Full Text] [Related]
13. [New option for successful therapy of chronic hepatitis B].
Ortleb J
Dtsch Med Wochenschr; 2003 Jul; 128(28-29):1565. PubMed ID: 12899163
[No Abstract] [Full Text] [Related]
14. [3 years' data of tenofovir. Confirmed as a valuable building block].
MMW Fortschr Med; 2004 Apr; 146 Spec No 1():30-1. PubMed ID: 15373042
[No Abstract] [Full Text] [Related]
15. Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B.
Patterson SJ; George J; Strasser SI; Lee AU; Sievert W; Nicoll AJ; Desmond PV; Roberts SK; Locarnini S; Bowden S; Angus PW
Gut; 2011 Feb; 60(2):247-54. PubMed ID: 21036792
[TBL] [Abstract][Full Text] [Related]
16. Low-density lipoprotein size and lipoprotein-associated phospholipase A2 in HIV-infected patients switching to abacavir or tenofovir.
Saumoy M; Ordoñez-Llanos J; Martínez E; Barragán P; Ribera E; Bonet R; Knobel H; Negredo E; Loncá M; Curran A; Gatell JM; Podzamczer D;
Antivir Ther; 2011; 16(4):459-68. PubMed ID: 21685533
[TBL] [Abstract][Full Text] [Related]
17. Letter: First-line monotherapies for chronic hepatitis B - indirect comparison between entecavir and tenofovir.
Maratea D; Fadda V; Trippoli S; Messori A
Aliment Pharmacol Ther; 2013 Mar; 37(5):584-5. PubMed ID: 23369168
[No Abstract] [Full Text] [Related]
18. Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. Checking up on ddI and tenofovir in people with HIV/AIDS.
TreatmentUpdate; 2003; 15(3):4-5. PubMed ID: 17216846
[No Abstract] [Full Text] [Related]
19. [Conclusions. Tenofovir].
Mallolas J
Enferm Infecc Microbiol Clin; 2008 Jun; 26 Suppl 8():62-4. PubMed ID: 19195439
[No Abstract] [Full Text] [Related]
20. [Treating chronic lamivudine-resistant hepatitis B in HIV co-infected patients].
Benhamou Y
Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S22-5. PubMed ID: 17075492
[No Abstract] [Full Text] [Related]
[Next] [New Search]
